Differentiation of effector CD4+ T cell populations

Annual Review of Immunology

Volumn 28, Issue , 2010, Pages 445-489

  Zhu, Jinfang ^a   Yamane, Hidehiro ^a   Paul, William E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CD4 effector T cells; Cytokines; Human diseases; Regulatory T cells; T cell differentiation; Transcription factors

Indexed keywords

GAMMA INTERFERON; IKAROS TRANSCRIPTION FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; MICRORNA; NOTCH RECEPTOR; PROTEIN BCL 6; STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR; CYTOKINE;

ADAPTIVE IMMUNITY; ALLERGIC REACTION; ASTHMA; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL FATE; CELL HETEROGENEITY; CELL LINEAGE; CELL POPULATION; CYTOKINE RELEASE; EFFECTOR CELL; EPIGENETICS; HELPER CELL; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PLASTICITY; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; TRANSCRIPTION REGULATION; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; CYTOKINES; HUMANS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 77952313777     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-030409-101212     Document Type: Review

References (310)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357
2. Killar L, MacDonald G, West J, Woods A, Bottomly K. 1987. Cloned, Ia-restricted T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells. J. Immunol. 138:1674-1679
3. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921-929
4. Swain SL, Weinberg AD, English M, Huston G. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796-3806
5. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091-1098
6. Hsieh CS, Heimberger AB, Gold JS, O'Garra A, Murphy KM. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89:6065-6069
7. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549
8. + T cells producing IL-2 or IL-4. J. Immunol. 148:1031-1036
9. + T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153:3514-3522
10. + T cells acts in an autocrine manner to induce Th2 differentiation. Eur. J. Immunol. 32:1428-1433
11. Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. 2001. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14:205-215
12. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, et al. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292:1907-1910
13. Zhu J, Guo L, Min B, Watson CJ, Hu-Li J, et al. 2002. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity 16:733-744
14. + thymocytes selected by MHC class I molecules. Science 263:1774-1778
15. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164
16. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, et al. 2003. Divergent pro-and antiinflammatory roles for IL-23 and IL-12 injoint autoimmune inflammation. J. Exp. Med. 198:1951-1957
17. + T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910-1914
18. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744-748
19. + T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141
20. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132
21. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189
22. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8:967-974
23. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, et al. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448:480-483
24. H 17 cells. Nature 448:484-487
25. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198:1875-1886
26. + CD25-precursors. Am. J. Transplant. 4:1614-1627
27. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172:5149-5153
28. - cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J. Immunol. 172:5213-5221
29. + regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol. 179:4685-4693
30. Tran DQ, Ramsey H, Shevach EM. 2007. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-13 dependent but does not confer a regulatory phenotype. Blood 110:2983-2990
31. King C, Tangye SG, Mackay CR. 2008. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 26:741-766
32. Reinhardt RL, Liang HE, Locksley RM. 2009. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 10:385-393
33. Zaretsky AG, Taylor JJ, King IL, Marshall FA, Mohrs M, Pearce EJ. 2009. T follicular helper cells differentiate from Th2 cells in response to helminth antigens. J. Exp. Med. 206:991-999
34. + T cells in reactive lymph nodes during helminth infection are T follicular helper cells. J. Exp. Med. 206:1001-1007
35. + T lymphocytes preferentially reside and rest in the bone marrow. Immunity 30:721-730
36. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10:595-602
37. H2 responses. Nature 458:351-356
38. Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, et al. 2009. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326:986-991
39. Lighvani AA, Frucht DM, Jankovic D, Yamane H, Aliberti J, et al. 2001. T-bet is rapidly induced by interferon-y in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98:15137-15142
40. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-725
41. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238
42. H17 lineage. Nature 441:231-234
43. KornT, Bettelli E, OukkaM, Kuchroo VK. 2009. IL-17 andTh17 cells. Annu. Rev. Immunol. 27:485-517
44. Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, et al. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29:138-149
45. Vogelzang A, McGuire HM, Yu D, Sprent J, Mackay CR, King C. 2008. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29:127-137
46. Guo L, Wei G, Zhu J, Liao W, Leonard WJ, et al. 2009. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc. Natl. Acad. Sci. USA 106:13463-13468
47. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, et al. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30:576-587
48. YangJ, Zhu H, Murphy TL, Ouyang W, Murphy KM. 2001. IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-y production. Nat. Immunol. 2:157-164
49. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, et al. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-y production and activates IRAK and NFKB. Immunity 7:571-581
50. + T cells. Cell 89:587-596
51. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272:21597-21603
52. Ho IC, Tai TS, Pai SY 2009. GATA3 and the T-cell lineage: essential functions before and after T helper-2-cell differentiation. Nat. Rev. Immunol. 9:125-135
53. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, et al. 1998. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9:745-755
54. Usui T, Preiss JC, Kanno Y, Yao ZJ, Bream JH, et al. 2006. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J. Exp. Med. 203:755-766
55. Ouyang W, Lohning M, Gao Z, Assenmacher M, Ranganath S, et al. 2000. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12:27-37
56. Zhang DH, Yang L, Cohn L, Parkyn L, Homer R, et al. 1999. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 11:473-482
57. H2 responses. Nat. Immunol. 5:1157-1165
58. Pai SY, Truitt ML, Ho IC. 2004. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc. Natl. Acad. Sci. USA 101:1993-1998
59. Siegel MD, Zhang DH, Ray P, Ray A. 1995. Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J. Biol. Chem. 270:24548-24555
60. Kishikawa H, Sun J, Choi A, Miaw SC, Ho IC. 2001. The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J. Immunol. 167:4414-4420
61. Yamashita M, Ukai-Tadenuma M, Kimura M, Omori M, Inami M, et al. 2002. Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus. J. Biol. Chem. 277:42399-42408
62. Agarwal S, Avni O, Rao A. 2000. Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo. Immunity 12:643-652
63. Zhu J, Yamane H, Cote-Sierra J, Guo L, Paul WE. 2006. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res. 16:3-10
64. Kim PJ, Pai SY, Brigl M, Besra GS, Gumperz J, Ho IC. 2006. GATA-3 regulates the development and function of invariant NKT cells. J. Immunol. 177:6650-6659
65. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655-669
66. H 1 gene induction. Nat. Immunol. 3:652-658
67. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295:338-342
68. Finotto S, Neurath MF, Glickman JN, Qin S, Lehr HA, et al. 2002. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295:336-338
69. + T cells. Nat. Immunol. 3:549-557
70. Cruz-Guilloty F, Pipkin ME, Djuretic IM, Levanon D, Lotem J, et al. 2009. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J. Exp. Med. 206:51-59
71. + T cell function by the transcription factor Eomesodermin. Science 302:1041-1043
72. + T cells lacking T-bet and Eomesodermin. Science 321:408-411
73. Suto A, Wurster AL, Reiner SL, Grusby MJ. 2006. IL-21 inhibits IFN-γ production in developing Th1 cells through the repression of Eomesodermin expression. J. Immunol. 177:3721-3727
74. + T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6:1236-1244
75. + T cell fates via the graded expression of T-bet transcription factor. Immunity 27:281-295
76. + T cells. J. Exp. Med. 204:2015-2021
77. Glimcher LH. 2007. Trawling for treasure: tales of T-bet. Nat. Immunol. 8:448-450
78. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, et al. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68-73
79. Patel DD. 2001. Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse. J. Clin. Investig. 107:155-157
80. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse Scurfy. Nat. Genet. 27:18-20
81. Fontenot JD, Gavin MA, Rudensky AY. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336
82. Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-1061
83. Williams LM, Rudensky AY. 2007. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8:277-284
84. Wan YY, Flavell RA. 2007. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445:766-770
85. Li MO, Wan YY, Flavell RA. 2007. T cell-produced transforming growth factor-|31 controls T cell tolerance and regulates Th1-and Th17-cell differentiation. Immunity 26:579-591
86. Li MO, Sanjabi S, Flavell RA. 2006. Transforming growth factor-|3 controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and-independent mechanisms. Immunity 25:455-471
87. Marie JC, Liggitt D, Rudensky AY. 2006. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-13 receptor. Immunity 25:441-454
88. + regulatory T cells. Nat. Immunol. 9:632-640
89. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9:194-202
90. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, et al. 2006. The orphan nuclear receptor RORyt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121-1133
91. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, et al. 2008. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR a and RORy. Immunity 28:29-39
92. Sun Z, Unutmaz D, Zou YR, Sunshine MJ, Pierani A, et al. 2000. Requirement for RORy in thymocyte survival and lymphoid organ development. Science 288:2369-2373
93. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, et al. 2009. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206:35-41
94. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589-592
95. Dent AL, Doherty TM, Paul WE, Sher A, Staudt LM. 1999. BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major. J. Immunol. 163:2098-2103
96. Kusam S, Toney LM, Sato H, Dent AL. 2003. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6. J. Immunol. 170:2435-2441
97. Scheeren FA, Naspetti M, Diehl S, Schotte R, Nagasawa M, et al. 2005. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat. Immunol. 6:303-313
98. Chtanova T, Tangye SG, Newton R, Frank N, Hodge MR, et al. 2004. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173:68-78
99. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, et al. 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192:1545-1552
100. Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, et al. 2009. Bcl6 mediates the development of T follicular helper cells. Science 325:1001-1005
101. Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, et al. 2009. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325:1006-1010
102. Yu D, Rao S, Tsai LM, Lee SK, He Y, et al. 2009. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31:457-468
103. Lieberman LA, Banica M, Reiner SL, Hunter CA. 2004. STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis. J. Immunol. 172:457-463
104. Park C, Li S, Cha E, Schindler C. 2000. Immune response in Stat2 knockout mice. Immunity 13:795-804
105. Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, et al. 2007. Cutting edge: An in vivo requirement for STAT3 signalinginTH17 development and TH17-dependent autoimmunity. J. Immunol. 179:4313-4317
106. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, et al. 2007. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J. Immunol. 178:4901-4907
107. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26:371-381
108. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, et al. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282:9358-9363
109. H17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773-776
110. Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, et al. 2006. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 103:8137-8142
111. Wei L, Laurence A, Elias KM, O'Shea JJ. 2007. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 282:34605-34610
112. -T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J. Immunol. 178:6725-6729
113. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, et al. 2008. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29:44-56
114. Kaplan MH, Sun YL, Hoey T, Grusby MJ. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174-177
115. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, et al. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171-174
116. Cai G, Radzanowski T, Villegas EN, Kastelein R, Hunter CA. 2000. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J. Immunol. 165:2619-2627
117. Usui T, Nishikomori R, Kitani A, Strober W. 2003. GATA-3 suppresses Th1 development by down-regulation of Stat4 and not through effects on IL-12Rβ2 chain or T-bet. Immunity 18:415-428
118. Frucht DM, Aringer M, Galon J, Danning C, Brown M, et al. 2000. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J. Immunol. 164:4659-4664
119. Lin JX, Leonard WJ. 2000. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19:2566-2576
120. Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, et al. 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10:249-259
121. Cote-Sierra J, Foucras G, Guo L, Chiodetti L, Young HA, et al. 2004. Interleukin 2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. USA 101:3880-3885
122. Zhu J, Cote-Sierra J, Guo L, Paul WE. 2003. Stat5 activation plays a critical role in Th2 differentiation. Immunity 19:739-748
123. Kagami S, Nakajima H, Suto A, Hirose K, Suzuki K, et al. 2001. Stat5a regulates T helper cell differentiation by several distinct mechanisms. Blood 97:2358-2365
124. Kagami S, Nakajima H, Kumano K, Suzuki K, Suto A, et al. 2000. Both stat5a and stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue. Blood 95:1370-1377
125. Takatori H, Nakajima H, Kagami S, Hirose K, Suto A, et al. 2005. Stat5a inhibits IL-12-induced Th1 cell differentiation through the induction of suppressor of cytokine signaling 3 expression. J. Immunol. 174:4105-4112
126. + T regulatory cells. J. Immunol. 178:4022-4026
127. + regulatory T cells. J. Immunol. 178:280-290
128. Burchill MA, Yang J, Vang KB, Moon JJ, Chu HH, et al. 2008. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28:112-121
129. Yao Z, Kanno Y, Kerenyi M, Stephens G, Durant L, et al. 2007. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109:4368-4375
130. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, et al. 2007. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13:711-718
131. Shi M, Lin TH, Appell KC, Berg LJ. 2008. Janus-kinase-3-dependent signals induce chromatin remodeling at the Ifng locus during T helper 1 cell differentiation. Immunity 28:763-773
132. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313-319
133. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630-633
134. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, et al. 1996. Essential role of Stat6 in IL-4 signaling. Nature 380:627-630
135. Kurata H, Lee HJ, O'Garra A, Arai N. 1999. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 11:677-688
136. Zhu J, Guo L, Watson CJ, Hu-Li J, Paul WE. 2001. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J. Immunol. 166:7276-7281
137. Lee DU, Rao A. 2004. Molecular analysis of a locus control region in the T helper 2 cytokine gene cluster: a target for STAT6 but not GATA3. Proc. Natl. Acad. Sci. USA 101:16010-16015
138. + lymphocytes with a Th2 cytokine profile. J. Immunol. 164:3047-3055
139. Finkelman FD, Morris SC, Orekhova T, Mori M, Donaldson D, et al. 2000. Stat6 regulation of in vivo IL-4 responses. J. Immunol. 164:2303-2310
140. Min B, Prout M, Hu-Li J, Zhu J, Jankovic D, et al. 2004. Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J. Exp. Med. 200:507-517
141. Voehringer D, Shinkai K, Locksley RM. 2004. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 20:267-277
142. van Panhuys N, Tang SC, Prout M, Camberis M, Scarlett D, et al. 2008. In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 105:12423-12428
143. Else KJ, Finkelman FD, Maliszewski CR, Grencis RK. 1994. Cytokine-mediated regulation of chronic intestinal helminth infection. J. Exp. Med. 179:347-351
144. Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM. 2007. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 8:145-153
145. Naoe Y, Setoguchi R, Akiyama K, Muroi S, Kuroda M, et al. 2007. Repression of interleukin-4 in T helper type 1 cells by Runx/Cbfβ binding to the Il4 silencer. J. Exp. Med. 204:1749-1755
146. Egawa T, Tillman RE, Naoe Y, Taniuchi I, Littman DR. 2007. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J. Exp. Med. 204:1945-1957
147. Ono M, Yaguchi H, Ohkura N, Kitabayashi I, Nagamura Y, et al. 2007. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446:685-689
148. + regulatory Tcells. Immunity 31:609-620
149. Rudra D, Egawa T, Chong MM, Treuting P, Littman DR, Rudensky AY. 2009. Runx-CBFβ complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 10:1170-1177
150. Bruno L, Mazzarella L, Hoogenkamp M, Hertweck A, Cobb BS, et al. 2009. Runx proteins regulate Foxp3 expression. J. Exp. Med. 206:2329-2337
151. + inducible regulatory T cells. J. Exp. Med. 206:2701-2715
152. Zhang F, Meng G, Strober W. 2008. Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9:1297-1306
153. Lohoff M, Mittrucker HW, Prechtl S, Bischof S, Sommer F, et al. 2002. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl. Acad. Sci. USA 99:11808-11812
154. Rengarajan J, Mowen KA, McBride KD, Smith ED, Singh H, Glimcher LH. 2002. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195:1003-1012
155. H-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8:958-966
156. + T cells. Nat. Immunol. 9:34-41 (Pubitemid 350286201)
157. Gilks CB, Bear SE, Grimes HL, Tsichlis PN. 1993. Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol. Cell. Biol. 13:1759-1768
158. Duan Z, Horwitz M. 2005. Gfi-1 takes center stage in hematopoietic stem cells. Trends Mol. Med. 11:49-52
159. Zhu J, Jankovic D, Grinberg A, Guo L, Paul WE. 2006. Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion. Proc. Natl. Acad. Sci. USA 103:18214-18219
160. + inducible regulatory T cells. J. Exp. Med. 206:329-341
161. Georgopoulos K, Winandy S, Avitahl N. 1997. The role of the Ikaros gene in lymphocyte development and homeostasis. Annu. Rev. Immunol. 15:155-176
162. Quirion MR, Gregory GD, Umetsu SE, Winandy S, Brown MA. 2009. Cutting edge: Ikarosisaregulator of Th2 cell differentiation. J. Immunol. 182:741-745
163. + regulatory T cells. Science 325:1142-1146
164. + T cells. Immunity 30:155-167
165. Kim JI, Ho IC, Grusby MJ, Glimcher LH. 1999. The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity 10:745-751
166. Hwang ES, White IA, Ho IC. 2002. An IL-4-independent and CD25-mediated function of c-maf in promoting the production of Th2 cytokines. Proc. Natl. Acad. Sci. USA 99:13026-13030
167. Bauquet AT, Jin H, Paterson AM, Mitsdoerffer M, Ho IC, et al. 2009. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10:167-175
168. Grenningloh R, Kang BY, Ho IC. 2005. Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses. J. Exp. Med. 201:615-626
169. Moisan J, Grenningloh R, Bettelli E, Oukka M, Ho IC. 2007. Ets-1 is a negative regulator of Th17 differentiation. J. Exp. Med. 204:2825-2835
170. Li B, Tournier C, Davis RJ, Flavell RA. 1999. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J. 18:420-432
171. Cimmino L, Martins GA, Liao J, Magnusdottir E, Grunig G, et al. 2008. Blimp-1 attenuates Th1 differentiation by repression of ifng, tbx21, and bcl6 gene expression. J. Immunol. 181:2338-2347
172. Martins G, Calame K. 2008. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu. Rev. Immunol. 26:133-169
173. + T cells. J. Immunol. 181:5249-5256
174. Venuprasad K, Huang H, Harada Y, Elly C, Subramaniam M, et al. 2008. The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat. Immunol. 9:245-253
175. VeldhoenM, Hirota K, Westendorf AM, Buer J, Dumoutier L, et al. 2008. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453:106-109
176. Veldhoen M, Hirota K, Christensen J, O'Garra A, Stockinger B. 2009. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 206:43-49
177. H17 differentiation. Nature 460:405-409
178. YangXO, AngkasekwinaiP, ZhuJ, PengJ, LiuZ, et al. 2009. Requirement for the basic helix-loop-helix transcription factor Dec2 in initial TH2 lineage commitment. Nat. Immunol. 10:1260-1266
179. Liu Z, Li Z, Mao K, Zou J, Wang Y, et al. 2009. Dec2 promotes Th2 cell differentiation by enhancing IL-2R signaling. J. Immunol. 183:6320-6329
180. Liao W, Schones DE, Oh J, Cui Y, Cui K, et al. 2008. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor a-chain expression. Nat. Immunol. 9:1288-1296
181. Thieu VT, Yu Q, Chang HC, Yeh N, Nguyen ET, et al. 2008. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity 29:679-690
182. H17 cell differentiation by antagonizing RORyt function. Nature 453:236-240
183. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, et al. 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126:375-387
184. Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH. 2005. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307:430-433
185. Zhu J, Paul WE. 2008. CD4T cells: fates, functions, and faults. Blood 112:1557-1569
186. H1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol. 7:425-428
187. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322
188. + T cells by antigenic peptides altered for TCR binding. J. Immunol. 158:4237-4244
189. + T cells. J. Immunol. 170:2427-2434
190. + T cells to generate a Th2-inducing cytokine environment. J. Exp. Med. 202:793-804
191. Yamashita M, Kimura M, Kubo M, Shimizu C, Tada T, et al. 1999. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc. Natl. Acad. Sci. USA 96:1024-1029
192. Yamashita M, Shinnakasu R, Asou H, Kimura M, Hasegawa A, et al. 2005. Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway. J. Biol. Chem. 280:29409-29419
193. lck tyrosine kinase activation in Th subset differentiation. Int. Immunol. 10:577-591 (Pubitemid 28221459)
194. lck. Nature 357:161-164
195. fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 70:741-750
196. fyn. Cell 70:751-763
197. + T cells into the Th2 subset. J. Immunol. 167:1962-1969
198. + T cells. J. Immunol. 181:5374-5385
199. Sharma P, Chakraborty R, Wang L, Min B, Tremblay ML, et al. 2008. Redox regulation of interleukin-4 signaling. Immunity 29:551-564
200. Lu X, Malumbres R, Shields B, Jiang X, Sarosiek KA, et al. 2008. PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling. Blood 112:4098-4108
201. Zhu J, Huang H, Guo L, Stonehouse T, Watson CJ, et al. 2000. Transient inhibition of interleukin 4 signaling by T cell receptor ligation. J. Exp. Med. 192:1125-1134
202. Schwartzberg PL, Finkelstein LD, Readinger JA. 2005. TEC-family kinases: regulators of T-helper-cell differentiation. Nat. Rev. Immunol. 5:284-295
203. + T cells. Immunity 11:399-409
204. Miller AT, Wilcox HM, Lai Z, Berg LJ. 2004. Signaling through Itk promotes T helper 2 differentiation via negative regulation of T-bet. Immunity 21:67-80
205. Gomez-RodriguezJ, SahuN, Handon R, Davidson TS, Anderson SM, et al. 2009. Differential expression of IL-17A and IL-17F is coupled to TCR signaling via Itk-mediated regulation of NFATc1. Immunity 31:587-597
206. Kashiwakura J, Suzuki N, Nagafuchi H, Takeno M, Takeba Y, et al. 1999. Txk, a nonreceptor tyrosine kinase of the Tec family, is expressed in T helper type 1 cells and regulates interferon γ production in human T lymphocytes. J. Exp. Med. 190:1147-1154
207. Takeba Y, Nagafuchi H, Takeno M, Kashiwakura J, Suzuki N. 2002. Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-γ gene transcription. J. Immunol. 168:2365-2370
208. Sahu N, Venegas AM, Jankovic D, Mitzner W, Gomez-Rodriguez J, et al. 2008. Selective expression rather than specific function of Txk and Itk regulate Th1 and Th2 responses. J. Immunol. 181:6125-6131
209. Schaeffer EM, Yap GS, Lewis CM, Czar MJ, McVicar DW, et al. 2001. Mutation of Tec family kinases alters T helper cell differentiation. Nat. Immunol. 2:1183-1188
210. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A. 2001. A critical role for NF-κB in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2:45-50
211. Nolan GP, Fujita T, Bhatia K, Huppi C, Liou HC, et al. 1993. The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol. Cell. Biol. 13:3557-3566
212. Corn RA, Hunter C, Liou HC, Siebenlist U, Boothby MR. 2005. Opposing roles for RelB and Bcl-3 in regulation of T-box expressed in T cells, GATA-3, and Th effector differentiation. J. Immunol. 175:2102-2110
213. Ghosh S, May MJ, Kopp EB. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260
214. Macian F. 2005. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5:472-484
215. Kiani A, Viola JP, Lichtman AH, Rao A. 1997. Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1. Immunity 7:849-860
216. Kiani A, Garcia-Cozar FJ, Habermann I, Laforsch S, Aebischer T, et al. 2001. Regulation of interferon-γ gene expression by nuclear factor of activated T cells. Blood 98:1480-1488
217. Diehl S, Chow CW, Weiss L, Palmetshofer A, Twardzik T, et al. 2002. Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation. J. Exp. Med. 196:39-49
218. Oukka M, Ho IC, de la Brousse FC, Hoey T, Grusby MJ, Glimcher LH. 1998. The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity 9:295-304
219. Ranger AM, Oukka M, Rengarajan J, Glimcher LH. 1998. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9:627-635
220. H cells. Nat. Immunol. 3:48-54
221. Yoshida H, Nishina H, Takimoto H, Marengere LE, Wakeham AC, et al. 1998. The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 8:115-124
222. Ranger AM, Hodge MR, Gravallese EM, Oukka M, Davidson L, et al. 1998. Delayed lymphoid repop-ulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 8:125-134
223. + T cells. J. Immunol. 168:3825-3832
224. Nurieva RI, DuongJ, Kishikawa H, Dianzani U, Rojo JM, et al. 2003. Transcriptional regulation of Th2 differentiation by inducible costimulator. Immunity 18:801-811
225. Kopan R, Ilagan MX. 2009. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137:216-233
226. Stanley P, Guidos CJ. 2009. Regulation of Notch signaling during T-and B-cell development by O-fucose glycans. Immunol. Rev. 230:201-215
227. + T cells. Immunity 19:549-559
228. Skokos D, Nussenzweig MC. 2007. CD8-DCs induce IL-12-independentTh1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J. Exp. Med. 204:1525-1531
229. Sun J, Krawczyk CJ, Pearce EJ. 2008. Suppression of Th2 cell development by Notch ligands Delta1 and Delta4. J. Immunol. 180:1655-1661
230. Shin HM, Minter LM, Cho OH, Gottipati S, Fauq AH, et al. 2006. Notch1 augments NF-KB activity by facilitating its nuclear retention. EMBOJ. 25:129-138
231. Palaga T, Miele L, Golde TE, Osborne BA. 2003. TCR-mediated Notch signaling regulates proliferation and IFN-y production in peripheral T cells. J. Immunol. 171:3019-3024
232. Minter LM, Turley DM, Das P, Shin HM, Joshi I, et al. 2005. Inhibitors of y-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat. Immunol. 6:680-688
233. + T helper cell fates by different Notch ligands on antigen-presenting cells. Cell 117:515-526
234. Tanigaki K, Tsuji M, Yamamoto N, Han H, Tsukada J, et al. 2004. Regulation of a|3/y5 T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. Immunity 20:611-622
235. Amsen D, Antov A, Jankovic D, Sher A, Radtke F, et al. 2007. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 27:89-99
236. Tu L, Fang TC, Artis D, Shestova O, Pross SE, et al. 2005. Notch signaling is an important regulator of type 2 immunity. J. Exp. Med. 202:1037-1042
237. Fang TC, Yashiro-Ohtani Y, Del Bianco C, Knoblock DM, Blacklow SC, Pear WS. 2007. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 27:100-110
238. Samon JB, Champhekar A, Minter LM, Telfer JC, Miele L, et al. 2008. Notch1 andTGFp1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood 112:1813-1821
239. Blokzijl A, Dahlqvist C, Reissmann E, Falk A, Moliner A, et al. 2003. Cross-talk between the Notch and TGF-13 signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J. Cell Biol. 163:723-728
240. Mukherjee S, Schaller MA, Neupane R, Kunkel SL, Lukacs NW. 2009. Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J. Immunol. 182:7381-7388
241. Ong CT, Sedy JR, Murphy KM, Kopan R 2008. Notch and presenilin regulate cellular expansion and cytokine secretion but cannot instruct Th1/Th2 fate acquisition. PLoS One 3:e2823
242. Adler SH, Chiffoleau E, Xu L, Dalton NM, Burg JM, et al. 2003. Notch signaling augments T cell responsiveness by enhancing CD25 expression. J. Immunol. 171:2896-2903
243. Wilson CB, Rowell E, SekimataM. 2009. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 9:91-105
244. Lee GR, Kim ST, Spilianakis CG, Fields PE, Flavell RA. 2006. T helper cell differentiation: regulation by cis elements and epigenetics. Immunity 24:369-379
245. Ansel KM, Djuretic I, Tanasa B, Rao A. 2006. Regulation of Th2 differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 24:607-656
246. Ansel KM, Greenwald RJ, Agarwal S, Bassing CH, Monticelli S, et al. 2004. Deletion of a conserved Il4 silencer impairs T helper type 1-mediated immunity. Nat. Immunol. 5:1251-1259
247. Agarwal S, Rao A. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9:765-775
248. Seki N, Miyazaki M, Suzuki W, Hayashi K, Arima K, et al. 2004. IL-4-induced GATA-3 expression is a time-restricted instruction switch for Th2 cell differentiation. J. Immunol. 172:6158-6166
249. Lee HJ, Takemoto N, Kurata H, Kamogawa Y, Miyatake S, et al. 2000. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J. Exp. Med. 192:105-115
250. Makar KW, Perez-Melgosa M, Shnyreva M, Weaver WM, Fitzpatrick DR, Wilson CB. 2003. Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat. Immunol. 4:1183-1190
251. Hutchins AS, Mullen AC, Lee HW, Sykes KJ, High FA, et al. 2002. Gene silencing quantitatively controls the function of a developmental trans-activator. Mol. Cell 10:81-91
252. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129:823-837
253. Schones DE, Cui K, Cuddapah S, Roh TY, Barski A, et al. 2008. Dynamic regulation of nucleosome positioning in the human genome. Cell 132:887-898
254. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, et al. 2008. High-resolution mapping and characterization of open chromatin across the genome. Cell 132:311-322
255. Yamashita M, Hirahara K, Shinnakasu R, Hosokawa H, Norikane S, et al. 2006. Crucial role of MLL for the maintenance of memory T helper type 2 cell responses. Immunity 24:611-622
256. Koyanagi M, Baguet A, Martens J, Margueron R, Jenuwein T, Bix M. 2005. EZH2 andhistone 3 trimethyl lysine 27 associated with Il4 and Il13 gene silencing in Th1 cells. J. Biol. Chem. 280:31470-31477
257. Miller SA, Huang AC, Miazgowicz MM, Brassil MM, Weinmann AS. 2008. Coordinated but physically separable interaction with H3K27-demethylase and H3K4-methyltransferase activities are required for T-box protein-mediated activation of developmental gene expression. Genes Dev. 22:2980-2993
258. Floess S, Freyer J, Siewert C, Baron U, Olek S, et al. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5:e38
259. Schoenborn JR, Dorschner MO, Sekimata M, Santer DM, Shnyreva M, et al. 2007. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-y. Nat. Immunol. 8:732-742
260. Lee DU, Avni O, Chen L, Rao A. 2004. A distal enhancer in the interferon-y (IFN-y) locus revealed by genome sequence comparison. J. Biol. Chem. 279:4802-4810
261. Hatton RD, Harrington LE, Luther RJ, Wakefield T, Janowski KM, et al. 2006. A distal conserved sequence element controls Ifng gene expression by T cells and NK cells. Immunity 25:717-729
262. SekimataM, Perez-MelgosaM, Miller SA, WeinmannAS, SaboPJ, et al. 2009. CCCTC-binding factor and the transcription factor T-bet orchestrate T helper 1 cell-specific structure and function at the interferon-y locus. Immunity 31:551-564
263. Mohrs M, Blankespoor CM, Wang ZE, Loots GG, Afzal V, et al. 2001. Deletion of a coordinate regulator of type 2 cytokine expression in mice. Nat. Immunol. 2:842-847
264. Solymar DC, Agarwal S, Bassing CH, Alt FW, Rao A. 2002. A 3' enhancer in the IL-4 gene regulates cytokine production by Th2 cells and mast cells. Immunity 17:41-50
265. Hural JA, KwanM, Henkel G, Hock MB, Brown MA. 2000. An intron transcriptional enhancer element regulates IL-4 gene locus accessibility in mast cells. J. Immunol. 165:3239-3249
266. Lee GR, Fields PE, Griffin TJ, Flavell RA. 2003. Regulation of the Th2 cytokine locus by a locus control region. Immunity 19:145-153
267. Lee GR, Spilianakis CG, Flavell RA. 2005. Hypersensitive site 7 of the TH2 locus control region is essential for expressing TH2 cytokine genes and for long-range intrachromosomal interactions. Nat. Immunol. 6:42-48
268. Akimzhanov AM, Yang XO, Dong C. 2007. Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. J. Biol. Chem. 282:5969-5972
269. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. 2008. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9:839-845
270. Carmell MA, Hannon GJ. 2004. RNase III enzymes and the initiation of gene silencing. Nat. Struct. Mol. Biol. 11:214-218
271. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, et al. 2005. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J. Exp. Med. 201:1367-1373
272. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K. 2005. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202:261-269
273. Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, et al. 2006. A role for Dicer in immune regulation. J. Exp. Med. 203:2519-2527
274. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, et al. 2009. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30:80-91
275. HaaschD, Chen YW, Reilly RM, Chiou XG, Koterski S, et al. 2002. Tcell activation inducesanoncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell. Immunol. 217:78-86
276. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316:604-608
277. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316:608-611
278. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237-1240
279. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737-742
280. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, et al. 2008. Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9:1341-1346
281. - effector T cells. Nat. Immunol. 9:1347-1355
282. + T cells in gut Peyer's patches. Science 323:1488-1492
283. Guo L, Hu-Li J, Zhu J, Watson CJ, Difilippantonio MJ, et al. 2002. In TH2 cells the Il4 gene has a series of accessibility states associated with distinctive probabilities of IL-4 production. Proc. Natl. Acad. Sci. USA 99:10623-10628
284. Guo L, Hu-Li J, Paul WE. 2005. Probabilistic regulation in TH2 cells accounts for monoallelic expression of IL-4 and IL-13. Immunity 23:89-99
285. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13:843-850
286. Chang HC, Zhang S, Thieu VT, Slee RB, Bruns HA, et al. 2005. PU. 1 expression delineates heterogeneity in primary Th2 cells. Immunity 22:693-703
287. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, et al. 2009. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10:1000-1007
288. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, et al. 2009. piggyBac transposition repro-grams fibroblasts to induced pluripotent stem cells. Nature 458:766-770
289. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676
290. Cobaleda C, Jochum W, Busslinger M. 2007. Conversion of mature B cells into T cells by dedifferenti-ation to uncommitted progenitors. Nature 449:473-477
291. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, et al. 2009. Late developmental plasticity in the T helper 17 lineage. Immunity 30:92-107
292. Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, et al. 2006. Inborn errors of IL-12/23-and IFN-γ-mediated immunity: molecular, cellular, and clinical features. Semin. Immunol. 18:347-361
293. Trinchieri G, Pflanz S, Kastelein RA. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19:641-644
294. de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, et al. 2008. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205:1543-1550
295. Khader SA, Cooper AM. 2008. IL-23 and IL-17 in tuberculosis. Cytokine 41:79-83
296. Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, et al. 2000. GATA3 haplo-insufficiency causes human HDR syndrome. Nature 406:419-422
297. Skapenko A, Leipe J, Niesner U, Devriendt K, Beetz R, et al. 2004. GATA-3 in human T cell helper type 2 development. J. Exp. Med. 199:423-428
298. Marrella V, Poliani PL, Sobacchi C, Grassi F, Villa A. 2008. Of Omenn and mice. Trends Immunol. 29:133-140
299. Turul T, Tezcan I, Artac H, de Bruin-Versteeg S, Barendregt BH, et al. 2009. Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency. Eur. J. Pediatr. 168:87-93
300. Milner JD, Ward JM, Keane-Myers A, Paul WE. 2007. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease. Proc. Natl. Acad. Sci. USA 104:576-581
301. + T cells are involved in the pathogenesis of an Omenn syndrome murine model. J. Clin. Investig. 117:1270-1281
302. Marrella V, Poliani PL, Casati A, Rucci F, Frascoli L, et al. 2007. A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J. Clin. Investig. 117:1260-1269
303. Buckley RH. 2001. The hyper-IgE syndrome. Clin. Rev. Allergy Immunol. 20:139-154
304. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, et al. 2007. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448:1058-1062
305. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, et al. 2007. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357:1608-1619
306. + T cells to enhance their antigen-driven expansion and differentiation. Proc. Natl. Acad. Sci. USA 106:7119-7124
307. Masters SL, Simon A, Aksentijevich I, Kastner DL. 2009. Horror autoinflammaticus: the molecular patho-physiology of autoinflammatory disease. Annu. Rev. Immunol. 27:621-668
308. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-21
309. Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW. 2007. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J. Allergy Clin. Immunol. 119:482-487
310. Belkaid Y, Tarbell K. 2009. Regulatory T cells in the control of host-microorganism interactions. Annu. Rev. Immunol. 27:551-589